Home / Resources / The New Standard: How AI Is Reshaping Trial Design, Execution, and Disclosure
STRATEGIC PLAYBOOK | Sept. 25, 2025

The New Standard: How AI Is Reshaping Trial Design, Execution, and Disclosure

This strategic playbook offers a blueprint for how leading teams are adopting AI in practical, measurable ways, from protocol feasibility and cohort modeling to clinical trial disclosure and transparency.

Download the playbook to learn more.

PDF preview of The New Standard: How AI Is Reshaping Trial Design, Execution, and Disclosure playbook, available for download.
Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.
Related products
''
Protocol SmartDesign
臨床試験の成功に向けて、主要評価項目とI/E基準の早期策定を支援します。
''
Investigator SmartSelect
臨床試験に最適な治験責任医師を、迅速かつ的確にリストアップできます。
Automated submissions to Clinical Trials
TrialScope Disclose
臨床試験情報開示の管理において最も広く信頼されているソリューション

Related resources

Preview cover for the Intelligent Compliance: Transforming Clinical Trial Disclosure with AI white paper
NOV 04, 2024
Whitepaper
薬事規制関連支援サービス

Intelligent Compliance: Transforming Clinical Trial Disclosure with AI

AI can help sponsors streamline clinical trial disclosure processes and meet the growing demands for timely and accessible information.

AI
OCT 11, 2024
Whitepaper
Clinical

【日本語版】製薬業界におけるAI：リスク、リターン、そして今後の展望

AIは、研究から承認、マーケティングに至るまで、医薬品開発プロセスのあらゆるステップを効率化・加速するために活用されています。

AI assistant in biotechnology science experiment
JUL 15, 2024
Article
Clinical

The Promise and Peril of AI in Clinical Trials

Many smaller organizations have not yet implemented a specialized clinical trial disclosure system. Robust transparency, and perhaps even just compliance with multiple regulators, requires commitment from the C-suite for companies of all sizes.

View all